Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Twist Bioscience Corporat...

    NASDAQ: TWST · Real-Time Price · USD
    26.97
    -0.11 (-0.41%)
    At close: Sep 17, 2025, 3:59 PM
    27.59
    2.30%
    Pre-market: Sep 18, 2025, 04:00 AM EDT
    -0.41%
    Bid 26.25
    Market Cap 1.63B
    Revenue (ttm) 362.27M
    Net Income (ttm) -85.19M
    EPS (ttm) -1.52
    PE Ratio (ttm) -17.74
    Forward PE -20.52
    Analyst Buy
    Dividends n/a
    Ask 28.63
    Volume 1,686,281
    Avg. Volume (20D) 1,659,040.1
    Open 27.30
    Previous Close 27.08
    Day's Range 26.50 - 28.24
    52-Week Range 24.07 - 55.33
    Beta 2.31
    Ex-Dividend Date n/a

    About TWST

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol TWST
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for TWST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Twist Bioscience Corporation is scheduled to release its earnings on Nov 17, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -10.3%
    Twist Bioscience shares are trading lower after th... Unlock content with Pro Subscription
    4 months ago
    -8.44%
    Twist Bioscience shares are trading lower after the company reported a Q2 EPS miss.
    news image

    3 weeks ago · seekingalpha.com

    mRNA Biotechs - Long-Term Value Risks Abound

    mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c...

    news image

    1 month ago · businesswire.com

    Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launche...

    news image

    1 month ago · seekingalpha.com

    Twist Bioscience: Headwinds Are Mounting

    Twist Bioscience's growth continues to moderate, in part due to macro headwinds. While Twist's focus on transitioning to profitability in the near-term has significantly reduced cash burn, it has also...

    news image

    1 month ago · zacks.com

    After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST)

    The heavy selling pressure might have exhausted for Twist Bioscience (TWST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street an...

    news image

    1 month ago · businesswire.com

    Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced the appointment of Trynka Shineman Blake to its board of direct...

    news image

    1 month ago · benzinga.com

    Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings

    What if a biotech company could flip its financial narrative from loss to profit in just a year? Twist Bioscience Corporation TWST has done just that, reporting a surprising third-quarter income that ...

    news image

    1 month ago · seekingalpha.com

    Twist Bioscience Corporation (TWST) Q3 2025 Earnings Call Transcript

    Twist Bioscience Corporation (NASDAQ:TWST ) Q3 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Adam Laponis - Chief Financial Officer Angela Bitting - Chief Corporate Resp...

    news image

    1 month ago · zacks.com

    Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

    Twist Bioscience (TWST) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.86 per share a year ago.

    news image

    1 month ago · businesswire.com

    Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter...

    news image

    1 month ago · businesswire.com

    Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

    Add to Watchlist